Message from the Chairperson

Takashi NAKAMURA, Chairperson

Medical Corporation HOUEIKAI is a Phase I unit of the Sekino Group, which is based on Sekino Hospital.

The clinical trial-related departments were transferred to HOUEIKAI from the group's Sekino Research Institute (established in 1988). HOUEIKAI has been conducting clinical trials centered on Phase I at the Sekino Clinical Pharmacology Clinic, which was approved as a medical institution specializing in clinical trials. The corporation’s philosophy is "Contribute to society as a partner in drug development by conducting rapid, safe, and high-quality clinical trials."

For the risk management of test subjects, we guarantee the safety through cooperation with adjacent Sekino Hospital in the same group and neighboring general hospital’s emergency department.

The nearest station to us is Ikebukuro Station, which is served by 8 lines. We are making use of the advantage of very good access in recruiting clinical trial volunteers.

In addition, we are deepening cooperation with other medical institutions and specialists in each department so that we can respond to the various needs of clinical trial sponsors.

HOUEIKAI will continue to devote ourselves to deeply study so that we can continue to contribute to medical care in Japan through clinical trials.